Filter results
You can narrow down the results using the filters
Search
95 result(s) found, displaying 51 to 75
- PublicationsCost Recovery Implementation Statement (CRIS): Regulation of medicinal cannabis, March 2020Information on how the Office of Drug Control implements cost recovery for regulatory activities associated with the direct costs of processing licence and permit applications for the cultivation of medicinal cannabis and the ongoing monitoring and compliance of the regulatory scheme.
- Application formsForm: Informed consentThis form authorises the Office of Drug Control (Department of Health and Aged Care) to obtain information on an individual named in an application for the grant or variation of a licence under the Narcotic Drugs Act 1967.
- PublicationsIndustry consultation paper: Medicinal cannabis cost recovery frameworkA comprehensive review of the Medicinal Cannabis Cost Recovery Framework was undertaken in
late 2019 and early 2020. This paper presents the findings of that review. - PublicationsConsultation paper: Single licence modelThe Government is inviting feedback on the proposal to implement a single medicinal cannabis licence under the Narcotic Drugs Act 1967 and other associated reforms to the licence application process.
- PublicationsHealth Products Regulation Group (HRPG) Regulatory Science Strategy, 2020-2025Our plan for how HPRG will maintain and build its regulatory science capability over the next 5 years.
- PublicationsExample follow-up questions for medicinal cannabis licence applicationsExample follow-up questions to assist applicants in preparing their medicinal cannabis licence applications.
- GuidelinesGuideline: Fit and proper persons and suitable staffGuideline to assist licence applicants and holders to assess whether they are fit and proper to hold a licence to cultivate, produce or manufacture medicinal cannabis and products.
- GuidelinesGuideline: Record keeping and reportingGuideline to assist licence applicants and holders in designing and meeting standards required for record keeping and reporting matters related to cultivation, production and manufacture of medicinal cannabis.
- Application formsApplication form: Licence to export narcotic, psychotropic and precursor substancesApplication form for a licence to export narcotic, psychotropic and precursor substances.
- Application formsApplication form: Permit to export narcotic, psychotropic and precursor substances from AustraliaInformation for applicants who intend to apply for a permit to export narcotic, psychotropic and precursor substances from Australia.
- PublicationsReview of the Narcotic Drugs Act 1967- Final report (2019)Review of the Narcotic Drugs Act 1967 - Final report authored by Professor John McMillan AO, published on 10 July 2019.
- PublicationsCost Recovery Implementation Statement (CRIS): Regulation of medicinal cannabis, November 2018Information on how the Office of Drug Control implements cost recovery for regulatory activities.
- PublicationsConsultation submissions: Kava pilot phase 1A total of 50 submissions were received in response to the public consultation between 22 Feb to 22 March 2019. Read the published submissions.
- PublicationsDiscussion paper: Review of the Narcotic Drugs Act 1967The 2016 amendments to the ND Act included a requirement in section 26A that the Minister cause a review of the operation of the Act to be undertaken as soon as possible after the second anniversary of the commencement of the 2016 amendments.
- PublicationsConsultation paper: Pilot Program to ease restrictions on the importation of kava for personal useThe Australian Government is exploring the appropriate mechanism to increase the quantity of kava that may be imported into Australia by incoming passengers for personal use.
- GuidanceGuidance note: Sponsored import and supply of unregistered medicinal cannabis products – Customs (Prohibited Imports) Regulations 1956Update to guidance on sponsored import and supply of unregistered medicinal cannabis products.
- GuidanceGuidance: Export of medicinal cannabisGuidance on export of medicinal cannabis and products.
- GuidanceGuidance note 2: Obtaining cannabis genetic material from international sourcesPolicy Circular #03/17
- PublicationsUsing cannabis for medicinal cannabis research and medical researchPolicy Circular #02/17
- PublicationsMedicinal cannabis cultivation and production licences - Testing of cannabis and cannabis resinPolicy Circular #01/17
- Application formsApplication form: Permit to import anabolic, androgenic, hormones and other controlled substancesApplication form for permission to import substances under Regulation 5G and 5H of the Customs (Prohibited Imports) Regulations 1956.
- Application formsApplication form: Pre-export notification (PEN) for a precursor substanceApplication form for a pre-export notification (PEN) for a precursor substance.
- Application formsApplication form: Pre-Export Notification (PEN) licenceApplication form for a licence to export precursor substances controlled under Regulation 10AB of the Customs (Prohibited Exports) Regulations 1958.
- LegislationCustoms (Prohibited Exports) Regulations 1958The Customs (Prohibited Exports) Regulations 1958 allow for export of prohibited substances with permission of administering agencies.
- Application formsApplication form: Addition of proposed import/export activities (of controlled substances) to an import/export licenceApplication form to vary an import and/or export licence (narcotic or psychotropic drugs or precursor substances) – Addition of proposed import/export activities (of controlled substances) to an import/export licence.